Resonant Link Medical Launches Vivigo™ 2.0 Wireless Power Platform

BURLINGTON, Vt., Sept. 29, 2026 /CourierPR/ -- Resonant Link Medical has unveiled Vivigo™ 2.0, an advanced wireless power platform designed to support the development of smaller, smarter, and longer-lasting implantable medical devices. This next-generation technology builds on the company's proven Aurion WPT™ platform and aims to reduce the development risk and accelerate the commercialization of innovative implantable devices.

The Vivigo™ 2.0 platform offers ultra-fast wireless energy transfer over an extended range, enabling the integration of continuous sensing, high-speed data transfer, artificial intelligence, and closed-loop algorithms. These capabilities require significantly more power than previous generations of implantable devices, making advanced wireless power essential for the next wave of intelligent medical technologies.

The platform supports both rechargeable implants, which can be charged in as little as 20 minutes, and battery-free devices requiring uninterrupted wireless power. This flexibility allows medical device companies to focus their time, energy, and innovation on creating the next generation of intelligent implantable medical devices, without needing to become wireless power experts themselves.

The launch of Vivigo™ 2.0 marks a significant step forward in the development of implantable medical devices, addressing the growing demand for more advanced and efficient power solutions. By providing a reliable and efficient wireless power platform, Resonant Link Medical is helping to drive innovation in the medical technology sector, enabling the creation of smaller, smarter, and longer-lasting implantable devices that can improve patient outcomes and quality of life.